Artrya Limited

Artrya Limited has 2 AI-enabled medical devices on the FDA list. The first decision was on March 27, 2025 and the most recent on August 20, 2025 (Salix Coronary Plaque (V1.0.0)). Its most common review panel is Radiology (2 devices).